ClinConnect ClinConnect Logo
Search / Trial NCT05135754

Investigation of Patient Benefits With a New Supporting Ostomy Product in Patients With a Newly Stoma Formation

Launched by COLOPLAST A/S · Nov 22, 2021

Trial Information

Current as of May 27, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Have provide written informed consent.
  • 2. Be at least 18 years of age and have full capacity.
  • 3. Have had their stoma for less than 9 months.
  • 4. Have intact skin on the peristomal area (assessed by investigator)
  • 5. Be able to use one of the five test products (i.e. Ø40, Ø50, Ø60, Ø70, Ø80 mm)
  • 6. Ileo- or colostomists with liquid and/or mushy output (Bristol scale type 5-7)
  • 7. Is willing to refrain from use of paste and protective sheets.
  • 8. Have a smartphone applicable for the HeyloTM app.
  • 9. Have been self-managing stoma appliance for at least 14 days.
  • 10. Are able to follow study procedures for 3 months (assessed by investigator)
  • 11. Are willing to receive their ostomy products through Coloplast Charter for the duration of the study.
  • Exclusion Criteria:
  • 1. Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
  • 2. Is breastfeeding.
  • 3. Is pregnant based on urine pregnancy test.
  • 4. Enrolled in another current research study or have previously participated in this investigation.
  • 5. Has known hypersensitivity towards any of the products used in the investigation.
  • 6. Is using/have a pacemaker.
  • 7. Has a complicated stoma at baseline (dehiscence/prolapse/hernia)
  • 8. Has limited life expectancy or receive palliative care.
  • 9. Has stage 4 cancer.
  • 10. Having more than one stoma synchronously
  • 11. Having ongoing non-healed abdominal wounds
  • 12. Reoperation / stoma reversal planned during the study period.

About Coloplast A/S

Coloplast A/S is a leading global medical device company headquartered in Denmark, specializing in products and services for individuals with intimate healthcare needs. With a strong commitment to innovation, Coloplast develops solutions in areas such as ostomy care, urology, and wound care. The company prioritizes patient-centered design, combining advanced technology with user-friendly applications to enhance quality of life for patients. Coloplast A/S actively conducts clinical trials to validate the safety and efficacy of its products, ensuring they meet the highest standards of care and contribute to improved health outcomes.

Locations

Newcastle, , United Kingdom

Bristol, , United Kingdom

Chelsea, , United Kingdom

Exeter, , United Kingdom

Great Yarmouth, , United Kingdom

Leeds, , United Kingdom

Manchester, , United Kingdom

Middlesbrough, , United Kingdom

Peterborough, , United Kingdom

Preston, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Richard Brady

Principal Investigator

Newcastle-upon-Tyne Hospitals NHS Trust

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials